Vlado Perkovic's Publications

• Efficacy and safety of canaglif lozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes

  Journal articles

  2015

  Diabetes Care

• The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study

  Journal articles

  2015

  Nephrology

• Blood pressure lowering in type 2 diabetes : A systematic review and meta-analysis

  Journal articles

  2015

  JAMA - Journal of the American Medical Association

• The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: Population based observational study

  Journal articles

  2015

  The BMJ

• Lowering cholesterol in chronic kidney disease: Is it safe and effective?

  Journal articles

  2015

  European Heart Journal

• Co-payments for health care: What is their real cost?

  Journal articles

  2015

  Australian Health Review

• A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial

  Journal articles

  2015

  American Journal of Kidney Diseases

• Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease

  Journal articles

  2015

  Cochrane Database of Systematic Reviews

• Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

  Journal articles

  2014

  New England Journal of Medicine

• Blood pressure-lowering treatment based on cardiovascular risk: A meta-analysis of individual patient data

  Journal articles

  2014

  The Lancet

• RESEARCH PRIORITIES IN CHRONIC KIDNEY DISEASE: A PRIORITY SETTING PARTNERSHIP

  Conference Papers

  2014

  NEPHROLOGY

• DIETARY SODIUM REDUCTION REDUCED ALBUMINURIA IN 1,903 RURAL CHINESE: A CLUSTER RANDOMISED TRIAL

  Conference Papers

  2014

  NEPHROLOGY

• The modifiable burden of worldwide mortality from cardiovascular diseases

  Journal articles

  2014

  LANCET DIABETES & ENDOCRINOLOGY

• THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL

  Journal articles

  2014

  NEPHROLOGY

• INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

  Journal articles

  2014

  NEPHROLOGY

• A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL

  Journal articles

  2014

  NEPHROLOGY

• Is it time for medi-change?

  Journal articles

  2014

  Medical Journal of Australia

• Long-term Efficacy and Safety of Linagliptin in Type 2 Diabetes Patients with Moderate to Severe Renal Disease

  Conference Papers

  2014

  DIABETES

• HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

  Journal articles

  2014

  Cochrane Database of Systematic Reviews

• The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy

  Journal articles

  2014

  Journal of the American Society of Nephrology

• Kidney Disease in Diabetes

  Book Chapters

  2014

  Managing Cardiovascular Complications in Diabetes

• kidney disease in diabetes

  Book Chapters

  2014

  Managing Cardiovascular Complications in Diabetes

• Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis

  Journal articles

  2014

  Nephrology Dialysis Transplantation

• HMG CoA reductase inhibitors (statins) for kidney transplant recipients

  Journal articles

  2014

  Cochrane Database of Systematic Reviews

• Authors reply to Ladapo and Ogedegbe

  Journal articles

  2014

  BMJ (Online)

• Cardiovascular disease in patients with chronic kidney disease

  Journal articles

  2014

  Nephrology